Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders

被引：18
|
作者：
Rowe, M
Niedobitek, G
Young, LS
机构：
[1] Cardiff Univ, Dept Med, Cardiff CF4 4XX, S Glam, Wales
[2] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany
[3] Univ Birmingham, Sch Med, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England
来源：
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1998年 / 20卷 / 3-4期
关键词：
D O I：
10.1007/BF00838051
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：389 / 403
页数：15
相关论文
共 50 条
  • [21] Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
    Shahid, Sanam
    Prockop, Susan E.
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 646 - 664
  • [22] Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
    Maud Salmona
    Karl Stefic
    Nadia Mahjoub
    Flore Sicre de Fontbrune
    Sarah Maylin
    François Simon
    Catherine Scieux
    Gérard Socié
    Marie-Christine Mazeron
    Jérôme LeGoff
    Virology Journal, 17
  • [23] THE EPSTEIN-BARR VIRUS IN THE PATHOGENESIS OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS - CLINICAL, PATHOLOGIC, AND VIROLOGIC CORRELATION
    HANTO, DW
    SAKAMOTO, K
    PURTILO, DT
    SIMMONS, RL
    NAJARIAN, JS
    SURGERY, 1981, 90 (02) : 204 - 213
  • [24] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in the skin
    Yamada, Kazuya
    Motegi, Sei-ichiro
    Amano, Hiroo
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2015, 42 (09): : 936 - 937
  • [25] Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder
    Kalra, Amit
    Roessner, Cameron
    Jupp, Jennifer
    Williamson, Tyler
    Tellier, Raymond
    Chaudhry, Ahsan
    Khan, Faisal
    Taparia, Minakshi
    Jimenez-Zepeda, Victor H.
    Stewart, Douglas A.
    Daly, Andrew
    Storek, Jan
    CYTOTHERAPY, 2018, 20 (05) : 706 - 714
  • [26] Significance of Epstein-Barr virus (EBV) load and Interleukin-10 in post-transplant lymphoproliferative disorders
    Muti, G
    Mancini, V
    Ravelli, E
    Morra, E
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1397 - 1407
  • [27] Immunohistochemical demonstration of Epstein-Barr virus nuclear antigens 1 and 2 in post-transplant lymphoproliferative disorders
    Chetty, R
    Biddolph, S
    Kaklamanis, L
    Kremmer, E
    Cary, N
    Stewart, S
    Parameshuar, J
    Giatromanolaki, A
    Gatter, K
    APPLIED IMMUNOHISTOCHEMISTRY, 1996, 4 (02): : 102 - 105
  • [28] Epstein-Barr virus driving post-transplant lymphoproliferative disorders: experience of the Swiss Pediatric Liver Center
    Rock, Nathalie M.
    Bouroumeau, Antoine
    Papangelopoulou, Danai
    Mainta, Ismini
    Katirtzidou, Eirini
    Wildhaber, Barbara E.
    L'Huillier, Arnaud G.
    Ansari, Marc
    McLin, Valerie A.
    Rougemont, Anne-Laure
    Baleydier, Frederic
    PEDIATRIC TRANSPLANTATION, 2023, 27
  • [29] Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy
    Nourse, J. P.
    Jones, K.
    Gandhi, M. K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (05) : 888 - 895
  • [30] Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load
    Hoshino, Y
    Kimura, H
    Kuzushima, K
    Tsurumi, T
    Nemoto, K
    Kikuta, A
    Nishiyama, Y
    Kojima, S
    Matsuyama, T
    Morishima, T
    BONE MARROW TRANSPLANTATION, 2000, 26 (02) : 199 - 201
12345